Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T03634 | Target Info | |||
Target Name | CREB-binding protein (CREBBP) | ||||
Synonyms | CREBbinding protein; CBP | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CREBBP | ||||
Biochemical Class | Acyltransferase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 1 Acid anhydride hydrolases | + | |||
Interacting Protein Name | X-ray repair cross-complementing protein 6 (XRCC6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CTC75; CTCBF; G22P1; KU70; ML8; TLAA | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Biochemical Activity | [1] | |||
3 | Reconstituted Complex | [2] | |||
4 | Yeast two hybrid | [2] | |||
Acyltransferases | [+] 6 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase KAT2B (KAT2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Spermidine acetyltransferase KAT2B; PCAF; P300/CBP-associated factor; P/CAF; Lysine acetyltransferase 2B; Histone acetyltransferase PCAF; Histone acetylase PCAF | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Co-fractionation | [3] | |||
4 | Reconstituted Complex | [5] | |||
5 | Reconstituted Complex | [4] | |||
6 | Reconstituted Complex | [6] | |||
7 | Yeast two hybrid | [6] | |||
Interacting Protein Name | Cyclic AMP-dependent transcription factor ATF-2 (ATF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRE.BP1; CREB.2; CREB2; HB16; TREB7 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [10] | |||
5 | Reconstituted Complex | [11] | |||
6 | Reconstituted Complex | [8] | |||
7 | Yeast two hybrid | [8] | |||
Interacting Protein Name | Breast cancer type 1 susceptibility protein (BRCA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Affinity Capture-Western | [13] | |||
3 | Affinity Capture-Western | [14] | |||
4 | Reconstituted Complex | [12] | |||
5 | Reconstituted Complex | [15] | |||
6 | Reconstituted Complex | [16] | |||
Interacting Protein Name | Nuclear receptor coactivator 1 (NCOA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | F.SRC.1; KAT13A; RIP160; SRC1; bHLHe42; bHLHe74 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Affinity Capture-Western | [17] | |||
3 | Reconstituted Complex | [18] | |||
4 | Reconstituted Complex | [19] | |||
5 | Reconstituted Complex | [20] | |||
6 | Yeast two hybrid | [19] | |||
Interacting Target Name | Nuclear receptor coactivator 3 (NCOA3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TRAM-1; TRAM1; Thyroid hormone receptor activator molecule 1; Steroid receptor coactivator protein 3; SRC-3; Receptor-associated coactivator 3; RAC-3; RAC3; PCIP; NCoA-3; Class E basic helix-loop-helix protein 42; CBP-interacting protein; bHLHe42; Amplified in breast cancer-1 protein; Amplified in breast cancer 1 protein; AIB1 (SRC-3); AIB-1; AIB1; ACTR | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Affinity Capture-Western | [21] | |||
3 | Reconstituted Complex | [22] | |||
4 | Reconstituted Complex | [17] | |||
5 | Yeast two hybrid | [17] | |||
Interacting Protein Name | SUMO-conjugating enzyme UBC9 (UBE2I) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C358B7.1; P18; UBC9 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Reconstituted Complex | [23] | |||
2 | Reconstituted Complex | [24] | |||
3 | Yeast two hybrid | [25] | |||
Glycosylases | [+] 1 Glycosylases | + | |||
Interacting Target Name | Thymine-DNA glycosylase (TDG) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Thymine-DNA glycosylase; hTDG | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Affinity Capture-Western | [26] | |||
3 | Biochemical Activity | [5] | |||
4 | Co-fractionation | [5] | |||
5 | Reconstituted Complex | [5] | |||
6 | Reconstituted Complex | [27] | |||
7 | Yeast two hybrid | [5] | |||
Kinases | [+] 5 Kinases | + | |||
Interacting Target Name | Fibroblast growth factor receptor 1 (FGFR1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT-2; FLT2; FLG; FGFR-1; FGFBR; c-fgr; CEK; CD331 antigen; CD331; bFGF-R-1; bFGF-R; BFGFR; Basic fibroblast growth factor receptor 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Affinity Capture-Western | [29] | |||
3 | Co-localization | [29] | |||
Interacting Target Name | Proto-oncogene c-Src (SRC) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase (pp60(src)); SRC1; Src tyrosine kinase; Proto-oncogene tyrosine-protein kinase Src; pp60c-src; Pp60(src); P60-Src; C-src TK; C-Src | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Co-localization | [30] | |||
3 | Reconstituted Complex | [31] | |||
Interacting Target Name | Casein kinase II alpha (CSNK2A1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein kinase CK2; CK2A1; CK II alpha; CK II; Casein kinase II subunit alpha | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [32] | |||
2 | Far Western | [33] | |||
3 | Reconstituted Complex | [33] | |||
Interacting Target Name | Inhibitor of nuclear factor kappa-B kinase alpha (IKKA) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor 16; TCF-16; TCF16; Nuclear factor NF-kappa-B inhibitor kinase alpha; Nuclear factor NFkappaB inhibitor kinase alpha; NFKBIKA; Inhibitory kappa B kinasea; Inhibitor of nuclear factor kappa-B kinase subunit alpha; IKK-alpha; IKK-A; IKK1; IkBKA; I-kappa-B kinase alpha; I-kappa-B kinase 1; IkappaB kinase; I kappa-B kinase alpha; Conserved helix-loop-helix ubiquitous kinase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Affinity Capture-Western | [35] | |||
3 | Yeast two hybrid | [34] | |||
Interacting Target Name | Inhibitor of nuclear factor kappa-B kinase beta (IKKB) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB; Inhibitory kappa B kinase b; Inhibitor of nuclear factor kappa-B kinase subunit beta; IKK-beta; IKKbeta; IKK-B; IKK-2; IKK2; IkBKB; I-kappa-B-kinase beta; IkappaB kinase beta; I-kappa-B kinase 2; IkappaB kinase 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Co-localization | [36] | |||
Membrane-bounded channels | [+] 1 Membrane-bounded channels | + | |||
Interacting Protein Name | Importin subunit alpha-1 (KPNA2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IPOA1; QIP2; RCH1; SRP1alpha | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [37] | |||
2 | Biochemical Activity | [38] | |||
Nuclear hormone receptors | [+] 5 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Reconstituted Complex | [40] | |||
4 | Yeast two hybrid | [39] | |||
5 | Yeast two hybrid | [41] | |||
Interacting Target Name | Hepatocyte nuclear factor 4-alpha (HNF4A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HNF-4; Transcription factor 14; TCF-14; TCF14; Nuclear receptor subfamily 2 group A member 1; NR2A1; HNF-4-alpha; HNF4 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [42] | |||
2 | Biochemical Activity | [43] | |||
3 | Reconstituted Complex | [44] | |||
4 | Reconstituted Complex | [45] | |||
5 | Yeast two hybrid | [44] | |||
Interacting Target Name | Peroxisome proliferator-activated receptor gamma (PPAR-gamma) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor PPAR gamma receptor; PPAR-gamma; PPARgamma; Peroxisome proliferator-activated receptor gamma; Nuclear receptor subfamily 1 group C member 3; NR1C3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Protein-peptide | [46] | |||
2 | Reconstituted Complex | [47] | |||
3 | Yeast two hybrid | [48] | |||
Interacting Target Name | Androgen receptor (AR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR; Androgen receptor | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [49] | |||
2 | Reconstituted Complex | [50] | |||
3 | Yeast two hybrid | [51] | |||
Interacting Target Name | Glucocorticoid receptor (NR3C1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear receptor subfamily 3 group C member 1; GRL; GR; Glucocorticoid receptor; Alpha-A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Reconstituted Complex | [53] | |||
One-carbon transferases | [+] 2 One-carbon transferases | + | |||
Interacting Target Name | Mixed-lineage leukemia protein (MLL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Zinc finger protein HRX; Trithorax-like protein; Trithoraxlike protein; p320; p180; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Myeloid/lymphoid or mixed-lineage leukemia; MLL1; MLL cleavage product C180; Lysine N-methyltransferase 2A; Lysine Nmethyltransferase 2A; HTRX; HRX; Histonelysine Nmethyltransferase MLL; Histone-lysine N-methyltransferase 2A; CXXC-type zinc finger protein 7; CXXCtype zinc finger protein 7; CXXC7; ALL-1; ALL1 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [54] | |||
2 | Co-crystal Structure | [55] | |||
3 | Co-crystal Structure | [56] | |||
4 | Reconstituted Complex | [55] | |||
5 | Reconstituted Complex | [54] | |||
6 | Reconstituted Complex | [57] | |||
7 | Yeast two hybrid | [54] | |||
Interacting Target Name | Histone-arginine methyltransferase CARM1 (CARM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein arginine N-methyltransferase 4; PRMT4; Histonearginine methyltransferase CARM1; Coactivator-associated arginine methyltransferase 1; Coactivatorassociated arginine methyltransferase 1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [58] | |||
2 | Biochemical Activity | [59] | |||
3 | Reconstituted Complex | [58] | |||
4 | Yeast two hybrid | [58] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [60] | |||
2 | Affinity Capture-Western | [35] | |||
3 | Affinity Capture-Western | [61] | |||
4 | Affinity Capture-Western | [62] | |||
5 | Biochemical Activity | [63] | |||
6 | Biochemical Activity | [64] | |||
7 | Biochemical Activity | [24] | |||
8 | Biochemical Activity | [65] | |||
9 | Biochemical Activity | [66] | |||
10 | Biochemical Activity | [67] | |||
11 | Biochemical Activity | [68] | |||
12 | Biochemical Activity | [69] | |||
13 | Co-crystal Structure | [70] | |||
14 | Protein-peptide | [71] | |||
15 | Reconstituted Complex | [72] | |||
16 | Reconstituted Complex | [73] | |||
17 | Reconstituted Complex | [60] | |||
18 | Reconstituted Complex | [18] | |||
19 | Reconstituted Complex | [68] | |||
20 | Reconstituted Complex | [74] | |||
Transcription regulators | [+] 33 Transcription regulators | + | |||
Interacting Target Name | Cyclic AMP-responsive element-binding protein (CREB1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-responsive element-binding protein 1; Cyclic AMP responseelement-binding protein; CREB-1; CREB; cAMP-responsive element-binding protein 1; CAMP-response element binding protein | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [75] | |||
2 | Affinity Capture-Western | [76] | |||
3 | Affinity Capture-Western | [10] | |||
4 | Affinity Capture-Western | [77] | |||
5 | Affinity Capture-Western | [78] | |||
6 | Affinity Capture-Western | [79] | |||
7 | Affinity Capture-Western | [80] | |||
8 | Affinity Capture-Western | [81] | |||
9 | Co-crystal Structure | [56] | |||
10 | Co-crystal Structure | [82] | |||
11 | Far Western | [83] | |||
12 | Far Western | [84] | |||
13 | Reconstituted Complex | [83] | |||
14 | Reconstituted Complex | [8] | |||
15 | Reconstituted Complex | [73] | |||
16 | Reconstituted Complex | [75] | |||
17 | Reconstituted Complex | [78] | |||
18 | Reconstituted Complex | [82] | |||
19 | Reconstituted Complex | [85] | |||
20 | Reconstituted Complex | [86] | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 18 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [87] | |||
2 | Affinity Capture-Western | [34] | |||
3 | Affinity Capture-Western | [35] | |||
4 | Affinity Capture-Western | [9] | |||
5 | Affinity Capture-Western | [88] | |||
6 | Affinity Capture-Western | [89] | |||
7 | Affinity Capture-Western | [90] | |||
8 | Affinity Capture-Western | [91] | |||
9 | Affinity Capture-Western | [92] | |||
10 | Affinity Capture-Western | [93] | |||
11 | Affinity Capture-Western | [94] | |||
12 | Reconstituted Complex | [95] | |||
13 | Reconstituted Complex | [11] | |||
14 | Reconstituted Complex | [20] | |||
15 | Reconstituted Complex | [91] | |||
16 | Reconstituted Complex | [96] | |||
17 | Yeast two hybrid | [91] | |||
18 | Yeast two hybrid | [34] | |||
Interacting Target Name | Interferon regulatory factor 3 (IRF3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRF-3 | ||||
Evidence Score (E-score) | 14 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [97] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Affinity Capture-Western | [98] | |||
4 | Affinity Capture-Western | [99] | |||
5 | Affinity Capture-Western | [88] | |||
6 | Affinity Capture-Western | [100] | |||
7 | Affinity Capture-Western | [101] | |||
8 | Affinity Capture-Western | [102] | |||
9 | Affinity Capture-Western | [103] | |||
10 | Affinity Capture-Western | [104] | |||
11 | Affinity Capture-Western | [105] | |||
12 | Affinity Capture-Western | [106] | |||
13 | Affinity Capture-Western | [107] | |||
14 | Reconstituted Complex | [108] | |||
Interacting Protein Name | Transcriptional activator Myb (MYB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcriptional activator Myb; Proto-oncogene c-Myb | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [109] | |||
2 | Biochemical Activity | [110] | |||
3 | Co-crystal Structure | [111] | |||
4 | Co-crystal Structure | [56] | |||
5 | Reconstituted Complex | [111] | |||
6 | Reconstituted Complex | [109] | |||
7 | Reconstituted Complex | [110] | |||
8 | Reconstituted Complex | [112] | |||
9 | Reconstituted Complex | [113] | |||
Interacting Target Name | Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor ISGF-3 components p91/p84; STAT-1; Signal transducers and activators of transcription factor; Signal transducer and activator of transcription 1-alpha/beta; P91 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [114] | |||
2 | Affinity Capture-Western | [94] | |||
3 | Affinity Capture-Western | [115] | |||
4 | Affinity Capture-Western | [116] | |||
5 | Biochemical Activity | [116] | |||
6 | Reconstituted Complex | [117] | |||
7 | Reconstituted Complex | [118] | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [119] | |||
2 | Affinity Capture-Western | [120] | |||
3 | Affinity Capture-Western | [60] | |||
4 | Affinity Capture-Western | [30] | |||
5 | Reconstituted Complex | [121] | |||
6 | Reconstituted Complex | [60] | |||
Interacting Target Name | Nuclear factor erythroid 2-related factor 2 (Nrf2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor, erythroid derived 2, like 2; NRF2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [89] | |||
2 | Affinity Capture-Western | [122] | |||
3 | Biochemical Activity | [122] | |||
4 | Reconstituted Complex | [123] | |||
5 | Yeast two hybrid | [123] | |||
Interacting Target Name | Transcription factor AP-1 (JUN) | Discontinued Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | V-jun avian sarcoma virus 17 oncogene homolog; Transcription factor AP-1; Proto-oncogene c-jun; P39; C-jun proto-oncogene; AP-1 transcription factor; AP1; Activator protein-1; Activator protein 1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Affinity Capture-Western | [124] | |||
3 | Far Western | [84] | |||
4 | Reconstituted Complex | [11] | |||
5 | Reconstituted Complex | [8] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; MMad3; MADH3; Mad3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [125] | |||
2 | Affinity Capture-Western | [126] | |||
3 | Affinity Capture-Western | [127] | |||
4 | Affinity Capture-Western | [128] | |||
5 | Yeast two hybrid | [129] | |||
Interacting Target Name | Kruppel like factor 4 (KLF4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Krueppel-like factor 4; Krueppellike factor 4; Gut-enriched krueppel-like factor; Gutenriched krueppellike factor; GKLF; EZF; Epithelial zinc finger protein EZF | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [130] | |||
2 | Biochemical Activity | [131] | |||
3 | Co-localization | [132] | |||
4 | Reconstituted Complex | [130] | |||
Interacting Target Name | Proto-oncogene c-Myc (MYC) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor p64; Proto-oncogene c-Myc; Myc proto-oncogene protein; C-myc oncogene; C-myc; Class E basic helix-loop-helix protein 39; bHLHe39 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [133] | |||
2 | Biochemical Activity | [134] | |||
3 | Reconstituted Complex | [134] | |||
4 | Yeast two hybrid | [134] | |||
Interacting Target Name | Forkhead box protein O1A (FOXO1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FOXO1A; Forkhead in rhabdomyosarcoma; Forkhead box protein O1A; Forkhead box protein O1; FKHR | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [135] | |||
2 | Affinity Capture-Western | [136] | |||
3 | Biochemical Activity | [135] | |||
4 | Reconstituted Complex | [137] | |||
Interacting Target Name | Transcription factor E2-alpha (TCF3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor ITF-1; Transcription factor 3; TCF-3; Kappa-E2-binding factor; ITF1; Immunoglobulin transcription factor 1; Immunoglobulin enhancer-binding factor E12/E47; E2A; Class B basic helix-loop-helix protein 21; bHLHb21 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Biochemical Activity | [138] | |||
2 | Biochemical Activity | [139] | |||
3 | Protein-peptide | [139] | |||
4 | Reconstituted Complex | [140] | |||
Interacting Protein Name | Homeobox protein Hox-B6 (HOXB6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HOX2; HOX2B; HU.2; Hox.2.2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [141] | |||
2 | Affinity Capture-Western | [142] | |||
3 | Reconstituted Complex | [141] | |||
4 | Reconstituted Complex | [142] | |||
Interacting Protein Name | Myoblast determination protein 1 (MYOD1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYF3; MYOD; PUM; bHLHc1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [143] | |||
2 | Biochemical Activity | [144] | |||
3 | Biochemical Activity | [64] | |||
4 | Reconstituted Complex | [143] | |||
Interacting Protein Name | Autoimmune regulator (AIRE) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AIRE1; APECED; APS1; APSI; PGA1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Far Western | [145] | |||
2 | Far Western | [146] | |||
3 | Yeast two hybrid | [145] | |||
4 | Yeast two hybrid | [146] | |||
Interacting Protein Name | Homeobox protein Hox-B7 (HOXB7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HHO.C1; HOX2; HOX2C; Hox.2.3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [142] | |||
2 | Reconstituted Complex | [147] | |||
3 | Reconstituted Complex | [142] | |||
4 | Yeast two hybrid | [147] | |||
Interacting Protein Name | Nuclear receptor coactivator 2 (NCOA2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GRIP1; KAT13C; NCoA.2; SRC2; TIF2; bHLHe75 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Reconstituted Complex | [148] | |||
2 | Reconstituted Complex | [149] | |||
3 | Reconstituted Complex | [150] | |||
4 | Yeast two hybrid | [149] | |||
Interacting Protein Name | Signal transducer and activator of transcription 2 (STAT2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ISGF.3; P113; STAT113 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [151] | |||
2 | Reconstituted Complex | [151] | |||
3 | Reconstituted Complex | [152] | |||
4 | Yeast two hybrid | [151] | |||
Interacting Target Name | Sterol regulatory element binding protein-1 (SREBF1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Sterol regulatory element-binding transcription factor 1; Sterol regulatory element-binding protein 1; SREBP-1; SREBP1; SREBP 1; Class D basic helix-loop-helix protein 1; bHLHd1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Far Western | [153] | |||
2 | Reconstituted Complex | [154] | |||
3 | Reconstituted Complex | [56] | |||
Interacting Protein Name | Serum response factor (SRF) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MCM1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [155] | |||
2 | Affinity Capture-Western | [156] | |||
3 | Yeast two hybrid | [156] | |||
Interacting Target Name | Signal transducer and activator of transcription 3 (STAT3) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor STAT3; Stat3; Signal transducer and activator of transcription 3; APRF; Acute-phase response factor | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [157] | |||
2 | Biochemical Activity | [158] | |||
Interacting Target Name | Hepatocyte nuclear factor 1-alpha (HNF1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor-1; Transcription factor 1; TCF-1; TCF1; Liver-specific transcription factor LF-B1; Liver specific transcription factor LF-B1; LFB1; HNF-1-alpha; HNF-1A; HNF-1 alpha | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [159] | |||
2 | Reconstituted Complex | [160] | |||
Interacting Target Name | E2F transcription factor 1 (E2F1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor E2F1; Retinoblastoma-binding protein 3; Retinoblastoma-associated protein 1; RBBP-3; RBBP3; RBAP-1; pRB-binding protein E2F-1; PBR3; E2F-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [161] | |||
2 | Yeast two hybrid | [162] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [163] | |||
2 | Affinity Capture-Western | [164] | |||
Interacting Target Name | Activating transcription factor 4 (ATF-4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TXREB; Tax-responsive enhancer element-binding protein 67; Taxresponsive enhancer elementbinding protein 67; TaxREB67; DNA-binding protein TAXREB67; DNAbinding protein TAXREB67; Cyclic AMP-responsive element-binding protein 2; Cyclic AMPresponsive elementbinding protein 2; Cyclic AMP-dependent transcription factor ATF-4; Cyclic AMPdependent transcription factor ATF4; CREB-2; CREB2; cAMP-responsive element-binding protein 2; cAMPresponsive elementbinding protein 2; cAMP-dependent transcription factor ATF-4; cAMPdependent transcription factor ATF4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-localization | [36] | |||
2 | Reconstituted Complex | [165] | |||
Interacting Target Name | Protein C-ets-1 (ETS1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P54; EWSR2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [124] | |||
2 | Reconstituted Complex | [166] | |||
Interacting Target Name | Proto-oncogene c-Fos (c-Fos) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Proto-oncogene c-Fos; G0S7; G0/G1 switch regulatory protein 7; C-fos; Cellular oncogene fos | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [167] | |||
2 | Reconstituted Complex | [40] | |||
Interacting Target Name | High mobility group protein HMG-I/Y (HMGA1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMGIY; HMG-I(Y); High mobility group protein R; High mobility group protein HMG-I/HMG-Y; High mobility group protein A1; High mobility group AT-hook protein 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [168] | |||
2 | Yeast two hybrid | [169] | |||
Interacting Protein Name | Forkhead box protein O4 (FOXO4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AFX; AFX1; MLLT7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [170] | |||
2 | Reconstituted Complex | [137] | |||
Interacting Protein Name | Hepatocyte nuclear factor 6 (ONECUT1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HNF.6; HNF6; HNF6A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [171] | |||
2 | Reconstituted Complex | [172] | |||
Interacting Protein Name | Myb-related protein A (MYBL1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | A.MYB; AMYB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [109] | |||
2 | Reconstituted Complex | [173] | |||
Interacting Protein Name | Sterol regulatory element-binding protein 2 (SREBF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SREBP.2; SREBP2; bHLHd2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [174] | |||
2 | Far Western | [153] | |||
Ubiquitin related proteins | [+] 3 Ubiquitin related proteins | + | |||
Interacting Protein Name | Anaphase-promoting complex subunit 7 (ANAPC7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APC7 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [175] | |||
2 | Affinity Capture-Western | [176] | |||
3 | Reconstituted Complex | [175] | |||
Interacting Protein Name | Small ubiquitin-related modifier 1 (SUMO1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DAP1; GMP1; OFC10; PIC1; SENP2; SMT3; SMT3C; SMT3H3; UBL1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Co-crystal Structure | [177] | |||
2 | Reconstituted Complex | [177] | |||
3 | Reconstituted Complex | [24] | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [178] | |||
2 | Biochemical Activity | [179] | |||
Other proteins | [+] 4 Other proteins | + | |||
Interacting Target Name | GAP-associated tyrosine phosphoprotein p62 (KHDRBS1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Src-associated in mitosis 68 kDa protein; Srcassociated in mitosis 68 kDa protein; Sam68; p68; p21 Ras GTPase-activating protein-associated p62; p21 Ras GTPaseactivating proteinassociated p62; KH domain-containing, RNA-binding, signal transduction-associated protein 1; KH domaincontaining, RNAbinding, signal transductionassociated protein 1; GAPassociated tyrosine phosphoprotein p62 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [180] | |||
2 | Affinity Capture-Western | [181] | |||
3 | Affinity Capture-Western | [182] | |||
4 | Biochemical Activity | [183] | |||
5 | Reconstituted Complex | [180] | |||
6 | Yeast two hybrid | [180] | |||
Interacting Protein Name | Promyelocytic leukemia protein (PML) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYL; PP8675; RNF71; TRIM19 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [155] | |||
2 | Affinity Capture-Western | [184] | |||
3 | Affinity Capture-Western | [185] | |||
4 | Reconstituted Complex | [184] | |||
Interacting Target Name | Huntingtin (HTT) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IT15; Huntington disease protein; Huntingtin; HD protein; HD | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [186] | |||
2 | Co-fractionation | [187] | |||
3 | Reconstituted Complex | [188] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [189] | |||
2 | Co-localization | [190] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell. 2004 Mar 12;13(5):627-38. | ||||
REF 2 | Repression of GCN5 histone acetyltransferase activity via bromodomain-mediated binding and phosphorylation by the Ku-DNA-dependent protein kinase complex. Mol Cell Biol. 1998 Mar;18(3):1349-58. | ||||
REF 3 | A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol. 1998 Sep;18(9):5355-63. | ||||
REF 4 | A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 1996 Jul 25;382(6589):319-24. | ||||
REF 5 | Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol Cell. 2002 Feb;9(2):265-77. | ||||
REF 6 | Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 1998 Jan 30;279(5351):703-7. | ||||
REF 7 | A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in br... J Biol Chem. 2006 Feb 3;281(5):2585-97. | ||||
REF 8 | CBP alleviates the intramolecular inhibition of ATF-2 function. J Biol Chem. 1998 Oct 30;273(44):29098-105. | ||||
REF 9 | Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis. J Biol Chem. 2007 May 18;282(20):15022-32. | ||||
REF 10 | Prostaglandin E2 signalling pathway in human T lymphocytes from healthy and conjunctiva basal cell carcinoma-bearing subjects. Immunol Cell Biol. 2001 Oct;79(5):482-9. | ||||
REF 11 | Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell. 1998 Jan;1(2):277-87. | ||||
REF 12 | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1020-5. | ||||
REF 13 | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. Exp Cell Res. 2006 Oct 1;312(16):3120-31. | ||||
REF 14 | New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines. Breast Cancer Res. 2006;8(1):R1. | ||||
REF 15 | Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res. 1998 Feb 1;26(3):847-53. | ||||
REF 16 | The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene. 1999 Jan 7;18(1):263-8. | ||||
REF 17 | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 1997 Jun 12;387(6634):677-84. | ||||
REF 18 | A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP. J Biol Chem. 2004 Apr 2;279(14):14055-64. | ||||
REF 19 | Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1. Mol Cell Biol. 2001 Jan;21(1):39-50. | ||||
REF 20 | Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J Virol. 2002 Sep;76(17):8710-21. | ||||
REF 21 | Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell. 2004 Sep 24;15(6):937-49. | ||||
REF 22 | A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996 May 3;85(3):403-14. | ||||
REF 23 | Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response. EMBO J. 2013 Mar 20;32(6):791-804. | ||||
REF 24 | Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation. Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5335-E5342. | ||||
REF 25 | A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions. Int J Biochem Cell Biol. 2012 Mar;44(3):547-55. | ||||
REF 26 | Thymine DNA glycosylase promotes transactivation of -catenin/TCFs by cooperating with CBP. J Mol Cell Biol. 2014 Jun;6(3):231-9. | ||||
REF 27 | SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment. Mol Cell Biol. 2007 Jan;27(1):229-43. | ||||
REF 28 | Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. J Biol Chem. 2005 Aug 5;280(31):28451-62. | ||||
REF 29 | A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. J Cell Biochem. 2012 Sep;113(9):2920-36. | ||||
REF 30 | Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci. 2005 Jan 15;118(Pt 2):301-11. | ||||
REF 31 | Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1. Biochem J. 2012 Mar 15;442(3):611-20. | ||||
REF 32 | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. Mol Endocrinol. 2005 Oct;19(10):2451-65. | ||||
REF 33 | Casein kinase II interacts with the bZIP domains of several transcription factors. Nucleic Acids Res. 1998 Aug 15;26(16):3854-61. | ||||
REF 34 | Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression. J Biol Chem. 2004 Jan 30;279(5):3509-15. | ||||
REF 35 | Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell. 2007 Apr 13;26(1):75-87. | ||||
REF 36 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 37 | Functional interaction of CREB binding protein (CBP) with nuclear transport proteins and modulation by HDAC inhibitors. Cell Cycle. 2006 Sep;5(18):2146-52. | ||||
REF 38 | Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr Biol. 2000 Apr 20;10(8):467-70. | ||||
REF 39 | Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment. J Mol Endocrinol. 2004 Feb;32(1):307-23. | ||||
REF 40 | p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 2002 Jan 1;62(1):141-51. | ||||
REF 41 | A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997 Jun 12;387(6634):733-6. | ||||
REF 42 | Critical structural elements and multitarget protein interactions of the transcriptional activator AF-1 of hepatocyte nuclear factor 4. J Biol Chem. 1998 Nov 6;273(45):29950-7. | ||||
REF 43 | Acetylation regulates transcription factor activity at multiple levels. Mol Cell. 2000 Apr;5(4):745-51. | ||||
REF 44 | Functional association between CBP and HNF4 in trans-activation. Biochem Biophys Res Commun. 1997 Dec 29;241(3):664-9. | ||||
REF 45 | CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J Biol Chem. 1999 Mar 26;274(13):9013-21. | ||||
REF 46 | Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor. Mol Cell Proteomics. 2009 Oct;8(10):2212-26. | ||||
REF 47 | Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol. 2000 Jul;20(13):4699-707. | ||||
REF 48 | A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. Anal Biochem. 2004 Dec 15;335(2):253-9. | ||||
REF 49 | Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell. 2010 Jun 15;17(6):535-46. | ||||
REF 50 | CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem. 1998 Nov 27;273(48):31853-9. | ||||
REF 51 | The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. J Mol Endocrinol. 2005 Feb;34(1):107-18. | ||||
REF 52 | Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription. J Biol Chem. 2010 Feb 12;285(7):4489-510. | ||||
REF 53 | Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors. Biochemistry. 1998 Jun 30;37(26):9586-94. | ||||
REF 54 | MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol. 2001 Apr;21(7):2249-58. | ||||
REF 55 | Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation do... J Biol Chem. 2002 Nov 8;277(45):43168-74. | ||||
REF 56 | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature. 2006 Aug 10;442(7103):700-4. | ||||
REF 57 | Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. J Mol Biol. 2007 Sep 28;372(4):958-69. | ||||
REF 58 | A transcriptional switch mediated by cofactor methylation. Science. 2001 Dec 21;294(5551):2507-11. | ||||
REF 59 | The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation. Mol Cell Biol. 2007 Jan;27(1):120-34. | ||||
REF 60 | Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300. J Biol Chem. 2010 Jan 22;285(4):2601-9. | ||||
REF 61 | Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol. 2006 Apr;26(7):2782-90. | ||||
REF 62 | A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy. Neoplasia. 2013 Aug;15(8):952-65. | ||||
REF 63 | Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011 Mar 10;471(7337):189-95. | ||||
REF 64 | Tat-controlled protein acetylation. J Biol Chem. 2002 Oct 4;277(40):37955-60. | ||||
REF 65 | MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 2002 Nov 15;21(22):6236-45. | ||||
REF 66 | Acetylation is indispensable for p53 activation. Cell. 2008 May 16;133(4):612-26. | ||||
REF 67 | CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16275-80. | ||||
REF 68 | Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell. 2004 Jan 30;13(2):251-63. | ||||
REF 69 | Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci. 2008 Aug 27;28(35):8772-84. | ||||
REF 70 | The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb. J Mol Biol. 2014 Dec 12;426(24):4030-4048. | ||||
REF 71 | Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19290-5. | ||||
REF 72 | CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 1997 Sep 1;57(17):3693-6. | ||||
REF 73 | p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation. Mol Cell Biol. 2000 Jul;20(13):4849-58. | ||||
REF 74 | p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300. J Biol Chem. 2002 Mar 15;277(11):9054-61. | ||||
REF 75 | Direct regulation of CREB transcriptional activity by ATM in response to genotoxic stress. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5898-903. | ||||
REF 76 | Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor. Endocrinology. 2003 Sep;144(9):3934-42. | ||||
REF 77 | Temporal recruitment of transcription factors at the 3',5'-cyclic adenosine 5'-monophosphate-response element of the human GnRH-II promoter. Endocrinology. 2008 Oct;149(10):5162-71. | ||||
REF 78 | Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17622-7. | ||||
REF 79 | Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation. J Mol Cell Cardiol. 2010 Aug;49(2):176-85. | ||||
REF 80 | Protein kinase C-theta participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the -180 site of the IL-2 promoter in normal human T lymphocytes. J Immunol. 2001 May 1;166(9):5665-74. | ||||
REF 81 | Tumor necrosis factor -induced hypoxia-inducible factor 1--catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling. Mol Cell Biol. 2013 Jul;33(14):2718-31. | ||||
REF 82 | Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell. 1997 Dec 12;91(6):741-52. | ||||
REF 83 | Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature. 1995 Mar 2;374(6517):85-8. | ||||
REF 84 | Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature. 1994 Jul 21;370(6486):226-9. | ||||
REF 85 | Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response eleme... J Biol Chem. 1996 Jul 26;271(30):17957-60. | ||||
REF 86 | Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB. Mol Cell Biol. 2000 Jul;20(14):4970-8. | ||||
REF 87 | PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. J Biol Chem. 2004 Jun 4;279(23):24873-80. | ||||
REF 88 | Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood. 2007 Apr 1;109(7):2887-93. | ||||
REF 89 | NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta. 2008 May;1783(5):713-27. | ||||
REF 90 | The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002 Mar;9(3):625-36. | ||||
REF 91 | CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2927-32. | ||||
REF 92 | High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-kappaB-CBP ternary complex in the cytoplasm. Oncogene. 2005 Jun 30;24(28):4521-30. | ||||
REF 93 | Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell. 2014 Oct 13;26(4):534-48. | ||||
REF 94 | Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression. Mol Cell Biol. 2015 May;35(10):1660-72. | ||||
REF 95 | Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol. 1997 Dec 1;159(11):5450-6. | ||||
REF 96 | Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation. Mol Cell Biol. 1999 Sep;19(9):6323-32. | ||||
REF 97 | Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol. 1998 May;18(5):2986-96. | ||||
REF 98 | Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation. J Immunol. 2006 Oct 15;177(8):5059-67. | ||||
REF 99 | Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol. 1999 Apr;19(4):2465-74. | ||||
REF 100 | Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem. 2007 Nov 2;282(44):32208-21. | ||||
REF 101 | Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology. 2007 Apr 10;360(2):305-21. | ||||
REF 102 | Crystal structure of IRF-3 in complex with CBP. Structure. 2005 Sep;13(9):1269-77. | ||||
REF 103 | HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 2001 Feb 15;20(7):800-11. | ||||
REF 104 | Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem. 2004 Feb 27;279(9):7643-54. | ||||
REF 105 | Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol. 2004 Nov;11(11):1060-7. | ||||
REF 106 | The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat Immunol. 2010 Aug;11(8):743-50. | ||||
REF 107 | Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-B activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. J Virol. 2013 Sep;87(17):9788-801. | ||||
REF 108 | Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur J Biochem. 2002 Dec;269(24):6142-51. | ||||
REF 109 | The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol Biol Cell. 2005 Oct;16(10):4705-13. | ||||
REF 110 | Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J Biol Chem. 2001 Feb 2;276(5):3674-82. | ||||
REF 111 | Roles of phosphorylation and helix propensity in the binding of the KIX domain of CREB-binding protein by constitutive (c-Myb) and inducible (CREB) activators. J Biol Chem. 2002 Nov 1;277(44):42241-8. | ||||
REF 112 | Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski. J Biol Chem. 2004 Apr 16;279(16):16715-26. | ||||
REF 113 | Structure of the transition state for the binding of c-Myb and KIX highlights an unexpected order for a disordered system. Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14942-7. | ||||
REF 114 | Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300. J Leukoc Biol. 2005 Aug;78(2):515-23. | ||||
REF 115 | Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner. J Immunol. 2009 Dec 1;183(11):6981-8. | ||||
REF 116 | Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev. 2006 Feb 15;20(4):473-85. | ||||
REF 117 | Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15092-6. | ||||
REF 118 | Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1074-9. | ||||
REF 119 | The zinc chelator, N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine, increases the level of nonfunctional HIF-1alpha protein in normoxic cells. Biochem Biophys Res Commun. 2006 May 19;343(4):1002-8. | ||||
REF 120 | Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Mol Pharmacol. 2008 Jul;74(1):236-45. | ||||
REF 121 | Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 1999 Jan 1;13(1):64-75. | ||||
REF 122 | Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol Cell Biol. 2009 May;29(10):2658-72. | ||||
REF 123 | Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells. 2001 Oct;6(10):857-68. | ||||
REF 124 | Extracellular signals regulate rapid coactivator recruitment at AP-1 sites by altered phosphorylation of both CREB binding protein and c-jun. Mol Cell Biol. 2008 Jul;28(13):4240-50. | ||||
REF 125 | Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 2005 Jul 20;24(14):2543-55. | ||||
REF 126 | The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein. Oncogene. 2004 Oct 28;23(50):8272-81. | ||||
REF 127 | Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation. J Biol Chem. 2009 Sep 4;284(36):23912-24. | ||||
REF 128 | Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell. Oncotarget. 2016 Oct 4;7(40):65553-65567. | ||||
REF 129 | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. J Biol Chem. 1999 Oct 1;274(40):28716-23. | ||||
REF 130 | Transactivation and growth suppression by the gut-enriched Krpel-like factor (Krpel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res. 2000 Mar 1;28(5):1106-13. | ||||
REF 131 | Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem. 2007 Nov 23;282(47):33994-4002. | ||||
REF 132 | Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors. Blood. 2011 Jun 9;117(23):6383-91. | ||||
REF 133 | Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene. 2007 Jan 18;26(3):382-94. | ||||
REF 134 | Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 2003 May;4(5):484-90. | ||||
REF 135 | Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10042-7. | ||||
REF 136 | CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. Mol Cancer Ther. 2014 Mar;13(3):687-98. | ||||
REF 137 | DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10412-7. | ||||
REF 138 | Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J Biol Chem. 2003 Jan 24;278(4):2370-6. | ||||
REF 139 | Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation. Biochim Biophys Acta. 2012 May;1819(5):375-81. | ||||
REF 140 | E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J Biol Chem. 2004 Dec 31;279(53):55362-71. | ||||
REF 141 | HOXB6 protein is bound to CREB-binding protein and represses globin expression in a DNA binding-dependent, PBX interaction-independent process. J Biol Chem. 2004 Sep 17;279(38):39895-904. | ||||
REF 142 | The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol. 2001 Nov;21(21):7509-22. | ||||
REF 143 | Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. Mol Cell Biol. 2001 Aug;21(16):5312-20. | ||||
REF 144 | CREB-binding protein/p300 activates MyoD by acetylation. J Biol Chem. 2000 Nov 3;275(44):34359-64. | ||||
REF 145 | The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem. 2000 Jun 2;275(22):16802-9. | ||||
REF 146 | P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain. J Bone Miner Res. 2003 Aug;18(8):1419-29. | ||||
REF 147 | CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene. 1999 Jul 8;18(27):4007-14. | ||||
REF 148 | MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. Mol Cell Biol. 2005 Feb;25(3):988-1002. | ||||
REF 149 | The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 1998 Jan 15;17(2):507-19. | ||||
REF 150 | EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. Nucleic Acids Res. 2005 Jun 24;33(11):3561-9. | ||||
REF 151 | Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature. 1996 Sep 26;383(6598):344-7. | ||||
REF 152 | Native Hydrophobic Binding Interactions at the Transition State for Association between the TAZ1 Domain of CBP and the Disordered TAD-STAT2 Are Not a Requirement. Biochemistry. 2017 Aug 15;56(32):4145-4153. | ||||
REF 153 | SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 1996 Nov 15;10(22):2903-11. | ||||
REF 154 | CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription. J Biol Chem. 1998 Jul 10;273(28):17865-70. | ||||
REF 155 | PML-nuclear bodies are involved in cellular serum response. Genes Cells. 2003 Mar;8(3):275-86. | ||||
REF 156 | The CREB-binding protein (CBP) cooperates with the serum response factor for transactivation of the c-fos serum response element. J Biol Chem. 1997 Dec 5;272(49):31016-21. | ||||
REF 157 | Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell. 2001 Feb 9;104(3):365-76. | ||||
REF 158 | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 2005 Jan 14;307(5707):269-73. | ||||
REF 159 | Transcriptional coactivators CBP and p300 cooperatively enhance HNF-1alpha-mediated expression of the albumin gene in hepatocytes. J Biochem. 2004 Sep;136(3):313-9. | ||||
REF 160 | Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J Biol Chem. 2000 Apr 28;275(17):12515-20. | ||||
REF 161 | The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 1996 Nov 1;24(21):4139-45. | ||||
REF 162 | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol Cell Biol. 2003 Jun;23(11):3707-20. | ||||
REF 163 | Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene. 2012 Nov 22;31(47):4946-59. | ||||
REF 164 | Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers. Oncotarget. 2014 Oct 15;5(19):9349-61. | ||||
REF 165 | Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP-responsive element-binding protein (CREB)-binding protein. J Biol Chem. 1997 Sep 19;272(38):24088-95. | ||||
REF 166 | A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol. 1998 Apr;18(4):2218-29. | ||||
REF 167 | Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol. 2005 Aug;25(16):6964-79. | ||||
REF 168 | Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell. 1998 Oct;2(4):457-67. | ||||
REF 169 | Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor. J Biol Chem. 1999 Aug 6;274(32):22563-8. | ||||
REF 170 | FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem. 2004 Jul 9;279(28):28873-9. | ||||
REF 171 | Association between hepatocyte nuclear factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity but inhibits HNF-6 DNA binding. Mol Cell Biol. 2003 Jan;23(2):437-49. | ||||
REF 172 | Transcriptional stimulation by hepatocyte nuclear factor-6. Target-specific recruitment of either CREB-binding protein (CBP) or p300/CBP-associated factor (p/CAF). J Biol Chem. 2000 Jul 21;275(29):22098-103. | ||||
REF 173 | Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules. Biochem J. 1997 Jun 15;324 ( Pt 3):729-36. | ||||
REF 174 | Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome. Mol Cell Biol. 2015 Jan;35(2):356-69. | ||||
REF 175 | The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. Nature. 2005 Dec 1;438(7068):690-5. | ||||
REF 176 | Mediator of DNA damage checkpoint 1 (MDC1) regulates mitotic progression. J Biol Chem. 2009 Dec 4;284(49):33939-48. | ||||
REF 177 | Structural Analysis of a Complex between Small Ubiquitin-like Modifier 1 (SUMO1) and the ZZ Domain of CREB-binding Protein (CBP/p300) Reveals a New Interaction Surface on SUMO. J Biol Chem. 2016 Jun 10;291(24):12658-72. | ||||
REF 178 | Coordinate regulation of estrogen receptor degradation by Mdm2 and CREB-binding protein in response to growth signals. Oncogene. 2013 Jan 3;32(1):117-26. | ||||
REF 179 | Inhibition of p53 degradation by Mdm2 acetylation. FEBS Lett. 2004 Mar 12;561(1-3):195-201. | ||||
REF 180 | Physical and functional interaction between the transcriptional cofactor CBP and the KH domain protein Sam68. Mol Cancer Res. 2002 Nov;1(1):48-55. | ||||
REF 181 | Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol. 2007 Oct;9(10):1208-15. | ||||
REF 182 | Sam68 Allows Selective Targeting of Human Cancer Stem Cells. Cell Chem Biol. 2017 Jul 20;24(7):833-844.e9. | ||||
REF 183 | The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity. Oncogene. 2004 May 6;23(21):3781-9. | ||||
REF 184 | Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2627-32. | ||||
REF 185 | A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat Genet. 1999 Nov;23(3):287-95. | ||||
REF 186 | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci. 2005 Dec;30(4):560-71. | ||||
REF 187 | Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001 Mar 23;291(5512):2423-8. | ||||
REF 188 | Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 2001 Oct 18;413(6857):739-43. | ||||
REF 189 | p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol Cell Biol. 2005 Mar;25(6):2419-30. | ||||
REF 190 | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature. 2016 Oct 6;538(7623):118-122. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.